Alliancebernstein L.P. Macrogenics Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Macrogenics Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 102,730 shares of MGNX stock, worth $334,899. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,730

Previous 102,730 -0.0%

Holding current value

$334,899

Previous $436,000 22.71%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.31 - $18.51 $118,167 - $660,807	35,700 Added 53.26%	102,730 $436,000
Q1 2024 May 14, 2024	SELL	$9.77 - $21.47 $396,368 - $871,037	-40,570 Reduced 37.7%	67,030 $986,000
Q4 2022 Feb 14, 2023	BUY	$3.34 - $6.98 $42,418 - $88,646	12,700 Added 13.38%	107,600 $721,000
Q3 2022 Nov 15, 2022	SELL	$3.01 - $5.22 $25,585 - $44,370	-8,500 Reduced 8.22%	94,900 $328,000
Q2 2022 Aug 15, 2022	SELL	$2.25 - $9.99 $95,694 - $424,884	-42,531 Reduced 29.14%	103,400 $305,000
Q1 2022 May 13, 2022	BUY	$8.12 - $16.9 $514,247 - $1.07 Million	63,331 Added 76.67%	145,931 $1.29 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $25,456 - $35,008	-1,600 Reduced 1.9%	82,600 $1.33 Million
Q1 2021 May 06, 2021	BUY	$18.99 - $33.2 $30,383 - $53,120	1,600 Added 1.94%	84,200 $2.68 Million
Q3 2020 Nov 12, 2020	SELL	$24.69 - $31.6 $29,628 - $37,920	-1,200 Reduced 1.43%	82,600 $2.08 Million
Q2 2020 Aug 13, 2020	BUY	$5.2 - $29.12 $43,680 - $244,608	8,400 Added 11.14%	83,800 $2.34 Million
Q1 2020 May 14, 2020	BUY	$4.28 - $12.11 $46,652 - $131,999	10,900 Added 16.9%	75,400 $439,000
Q2 2019 Aug 14, 2019	BUY	$14.51 - $19.71 $330,828 - $449,388	22,800 Added 54.68%	64,500 $1.1 Million
Q1 2018 May 14, 2018	SELL	$18.89 - $32.46 $24,557 - $42,198	-1,300 Reduced 3.02%	41,700 $1.05 Million
Q3 2017 Nov 13, 2017	BUY	$15.52 - $18.94 $667,360 - $814,420	43,000	43,000 $795,000

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Macrogenics Inc Transaction History